CJC-1295 With DAC vs Without DAC: What Changes in Research
·
Written by: Dr. James Nguyen, MD (Neurosurgeon)
CJC-1295 is a GHRH analogue used in pulsatile GH-release research. Catalogs list forms without DAC and with DAC (Drug Affinity Complex). The modification changes pharmacokinetic framing; the SKUs are not interchangeable tools.
What DAC Means
DAC chemistry is designed so the peptide can form a covalent albumin adduct in biological systems, generally extending residence time versus the unmodified analogue. Without DAC, researchers study a shorter-acting GHRH-receptor agonist; with DAC, a longer-exposure stimulus.
Study Design Implications
- Match sampling windows to kinetics.
- Do not equate sustained exposure with an acute pulse when pulse architecture is the endpoint.
- Specify CJC form in GHRP combination studies.
- Use separate COAs for each SKU.
| Variable | Without DAC | With DAC |
|---|---|---|
| Albumin-reactive complex | No | Yes (design intent) |
| Typical framing | Shorter-acting | Extended-exposure |
| Matched endpoints | Acute pulse | Longer windows |
Related: peptide half-life.
Research Materials at BLL Peptides
GHRH-axis research materials:
- CJC-1295 10mg (3ml): without DAC
- CJC-1295 with DAC 5mg (3ml): with DAC
- CJC-1295/Ipamorelin 5/5mg (3ml): GHRH+GHRP blend
All products are intended for research purposes only and are not intended for human consumption.
Frequently Asked Questions
Q: DAC meaning?
Drug Affinity Complex for albumin interaction / extended exposure framing.
Q: Interchangeable?
No.
Q: Pulse studies?
Without DAC usually easier to align; validate in model.
Q: Human use?
No.
Operational Checklist for Labs
Store each SKU under the labeled conditions, and never relabel a with-DAC vial as “CJC-1295” without the modifier. In electronic inventories, use distinct item codes. When writing methods, name the exact catalog form, lot, and whether albumin-reactive chemistry is present.
If a protocol historically used one form, switching forms is a method change: re-validate time points, exposure windows, and any combination schedule with GHRP-class reagents. Downstream GH-axis readouts can shift simply because kinetics shifted.
What Not to Infer
Extended exposure is not automatically “better,” and shorter action is not automatically “more physiologic.” The right choice is the one that matches the hypothesis. Avoid informal potency rankings drawn from mismatched sampling designs.
Takeaway for Research Teams
Standardize documentation, preserve lot traceability, and design controls that can falsify your hypothesis. Those habits matter more than adding unverified claims to a methods section. Keep every vial labeled research use only, and keep calculations, diluents, and storage conditions in the notebook beside the biological endpoints.
When results surprise you, audit the reagent identity and preparation trail before rewriting the biological story. Most “mysterious” peptide findings begin as ordinary handling or labeling mismatches.
Scope Reminder
All materials discussed here are research reagents. Nothing in this article authorizes human administration, clinical protocols, or consumer supplementation narratives. Keep inventory labels, invoices, and lab SOPs aligned with research-use-only language, and route any human-use questions to appropriate medical/regulatory channels outside this catalog context.
This content is intended for research and educational purposes only. It is not medical advice. BLL Peptides products are for research use only and are not intended for human consumption.
